TipRanks
Go Ultimate55% OFF

BioNexus Gene Lab Corp (BGLC) Ownership - Who Owns BioNexus Gene Lab Corp?

BioNexus Gene Lab Corp (BGLC) Ownership Overview

  • 17.64% Insiders
  • 1.63% Other Institutional Investors
  • 80.73% Public Companies and Individual Investors

The ownership structure of BioNexus Gene Lab Corp (BGLC) stock is a mix of institutional, retail, and individual investors. Approximately 1.63% of the company’s stock is owned by Institutional Investors, 17.64% is owned by Insiders, and 80.73% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

BGLC top shareholders
Holder# of SharesType% HoldingValue
Lee Su-leng Tan338,709Insider11.55%340,064
Set Fui Chong96,774Insider3.30%97,161
Chee Keong Yap32,258Insider1.10%32,387
Muhammad Azrul Bin Abdul Hamid32,258Insider1.10%32,387
Jook Yuen Low17,390Insider0.59%17,460

FAQ

Who Owns BioNexus Gene Lab Corp (BGLC)?
According to the latest TipRanks data, approximately 1.63% of the company's stock is held by institutional investors, 17.64% is held by insiders, and 80.73% is held by public companies and individual investors.
What percentage of BioNexus Gene Lab Corp (BGLC) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.63% of BioNexus Gene Lab Corp (BGLC) stock is held by institutional investors.
What percentage of BioNexus Gene Lab Corp (BGLC) stock is held by retail investors?
According to the latest TipRanks data, approximately 80.73% of BioNexus Gene Lab Corp (BGLC) stock is held by public companies and individual investors.
Who owns the most shares of BioNexus Gene Lab Corp (BGLC)?
Lee Su-Leng Tan owns the most shares of BioNexus Gene Lab Corp (BGLC).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.